Halozyme Therapeutics shares owned by 361 Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by 361 Capital
from 13F filings
Historical chart of 361 Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by 361 Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by 361 Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-06-30 | $1.1M | 41k | 26.82 |
| 2020-03-31 | $841k | 47k | 18.00 |
| 2019-12-31 | $1.4M | 77k | 17.73 |
| 2019-09-30 | $2.5M | 162k | 15.51 |
| 2019-06-30 | $2.8M | 166k | 17.18 |
| 2019-03-31 | $2.9M | 178k | 16.10 |
| 2018-12-31 | $2.3M | 160k | 14.63 |
| 2017-12-31 | $1.4M | 68k | 20.26 |
| 2017-09-30 | $207k | 12k | 17.38 |